The two most common behaviors caused by Alzheimer’s disease are agitation (including aggression) and wandering. These fall under a broader category called behavioral and psychological symptoms of dementia, which affect roughly 68% of people living with the disease. Both behaviors become more frequent and intense as cognitive decline progresses, and they are among the primary reasons families eventually seek residential care.
Agitation and Aggression
Agitation in Alzheimer’s shows up as restlessness, pacing, verbal outbursts, and sometimes physical aggression. It affects 30 to 50% of people with the disease at some point. Unlike the occasional frustration anyone might feel, Alzheimer’s-related agitation is often undirected, meaning it can flare without any obvious provocation. A person might suddenly become combative during bathing, refuse to eat, or shout repeatedly without being able to explain why.
The behavior stems from damage to areas of the brain responsible for emotional regulation. As Alzheimer’s progresses, tangles of abnormal protein accumulate in regions that normally help a person process emotions, weigh social cues, and inhibit impulsive reactions. When those circuits break down, the brain loses its ability to modulate emotional responses. The result is that minor frustrations, confusion, or physical discomfort can trigger reactions far out of proportion to the situation.
Environmental factors play a major role too. Overstimulating settings, unfamiliar people, pain that the person can’t articulate, or a disrupted routine can all spark agitation. One well-documented pattern is called sundowning: a worsening of agitation, anxiety, and confusion that appears in the late afternoon or evening. Sundowning is tied to degeneration of the brain’s internal clock. In a healthy brain, a small structure called the suprachiasmatic nucleus keeps daily rhythms on track, partly influenced by signals from regions that Alzheimer’s damages early. As those structures deteriorate, the body loses its ability to match activity levels to the time of day. Melatonin production also drops because of physical changes to the pineal gland, making it harder for the brain to prepare for sleep. The result is nighttime hyperactivity that often takes the form of aggression or restless wandering.
Of all behavioral symptoms, agitation takes the heaviest toll on caregivers. In a study measuring caregiver burden and depression, agitation was the only symptom that remained strongly linked to both outcomes after accounting for other factors like the caregiver’s age, relationship to the patient, and the severity of dementia. Sleep disturbances also contributed to caregiver depression, but agitation was consistently the strongest driver of stress and exhaustion.
Wandering
Up to 60% of people with Alzheimer’s will wander at some point during the course of their illness, and the rate climbs even higher in residential care settings, where estimates reach 63%. Wandering can look like aimless pacing inside the home, repeatedly trying to leave, or walking away from a safe location with no clear destination. Some people wander because they believe they need to go somewhere, perhaps to a job they held decades ago or a childhood home. Others simply walk without any apparent goal.
The neurological roots of wandering are tied to damage in areas that handle spatial awareness and navigation. Alzheimer’s impairs the ability to form mental maps, recognize familiar landmarks, and orient to time and place. Imaging studies show reduced blood flow in brain regions responsible for visuospatial processing, which explains why a person can get lost in a neighborhood they’ve lived in for 30 years. Wandering becomes more likely as cognitive impairment deepens. Clinically, it correlates with scores of 13 or below on a 30-point cognitive screening test, reflecting severe deficits in both recent and remote memory.
The danger of wandering is immediate and physical. A person who leaves the house disoriented may be unable to find their way back, cross busy streets without awareness of traffic, or be exposed to weather extremes. This makes wandering one of the most anxiety-producing behaviors for families and one of the leading triggers for moving a loved one into a care facility.
Why These Behaviors Escalate
Both agitation and wandering tend to worsen as Alzheimer’s progresses, but not on a smooth, predictable curve. Infections, medication changes, constipation, dehydration, or even a change in lighting can cause a sudden spike in either behavior. Because people with moderate to advanced Alzheimer’s often can’t describe what they’re feeling, behavioral changes sometimes serve as the only signal that something else is wrong physically. A sudden increase in agitation, for example, may actually reflect an undiagnosed urinary tract infection or unmanaged pain.
The interplay between neurological damage and the surrounding environment is central. A noisy room, an unfamiliar caregiver, or being asked to do something beyond the person’s remaining abilities can trigger agitation or wandering in someone who was calm moments before. This is why the context around a behavior matters as much as the behavior itself.
Managing Agitation and Wandering
Non-drug approaches are the first line of management and, for many people, the most effective. The strongest evidence supports interventions that are tailored to the individual rather than applied as a blanket strategy. In a large review of behavioral interventions, 85% of the approaches rated as effective included some form of personalization based on the person’s preferences, history, or current mood. Music therapy is a good example: rather than playing generic calming music, programs that let the person choose songs connected to their own memories show significantly better results for reducing anxiety and agitation.
Environmental modifications also help. For wandering, this means secured outdoor walking paths, clear visual cues like colored tape on doors that should stay closed, and consistent daily routines that reduce confusion. For agitation, reducing background noise, ensuring adequate lighting (especially in the late afternoon to counteract sundowning), and maintaining a predictable schedule can prevent episodes before they start. Ongoing caregiver training is another factor: when caregivers receive sustained support and coaching rather than a single workshop, behavioral outcomes improve substantially.
On the medication side, the FDA approved brexpiprazole in May 2023 as the first drug specifically indicated for agitation in Alzheimer’s disease. Before that approval, clinicians had no medication formally designated for this purpose, though various drugs were used off-label. Medication is typically reserved for situations where agitation poses a safety risk and non-drug strategies haven’t been enough.
Impact on Caregivers and Families
Behavioral symptoms are a leading cause of institutionalization, often more so than memory loss itself. Families can adapt to forgetfulness and repetitive questions, but around-the-clock vigilance for wandering or managing daily episodes of aggression creates a level of stress that is difficult to sustain. Caregivers of people with behavioral symptoms report lower quality of life, higher rates of depression, and greater overall burden compared to caregivers of people whose Alzheimer’s is primarily cognitive. Agitation, hallucinations, disinhibition, irritability, and sleep disturbances are all independently linked to increased caregiver burden, but agitation stands out as the single strongest predictor of both caregiver depression and feelings of being overwhelmed.
Roughly 30% of people with Alzheimer’s experience three or more behavioral symptoms in any given month, meaning caregivers are often managing several challenging behaviors simultaneously rather than dealing with just one. Recognizing that these behaviors are symptoms of brain disease, not deliberate choices, can help reframe the experience, but it doesn’t eliminate the practical toll of living with them day after day.